Issued Patents All Time
Showing 1–25 of 77 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10662252 | Disease therapy by inducing immune response to Trop-2 expressing cells | Chien-Hsing Chang, David M. Goldenberg, Diane Rossi | 2020-05-26 |
| 10308688 | T-cell redirecting bispecific antibodies for treatment of disease | Chien-Hsing Chang, David M. Goldenberg, Diane Rossi | 2019-06-04 |
| 10245321 | Combination therapy for inducing immune response to disease | Chien-Hsing Chang, David M. Goldenberg, Diane Rossi, Hans J. Hansen | 2019-04-02 |
| 10239938 | T-cell redirecting bispecific antibodies for treatment of disease | Chien-Hsing Chang, David M. Goldenberg, Diane Rossi, Hans J. Hansen | 2019-03-26 |
| 10183992 | T-cell redirecting bispecific antibodies for treatment of disease | Chien-Hsing Chang, David M. Goldenberg, Diane Rossi | 2019-01-22 |
| 10131712 | Combination therapy with T-cell redirecting bispecific antibodies and checkpoint inhibitors | Chien-Hsing Chang, David M. Goldenberg | 2018-11-20 |
| 10111954 | Combination therapy for inducing immune response to disease | Chien-Hsing Chang, David M. Goldenberg, Diane Rossi, Hans J. Hansen | 2018-10-30 |
| 9963516 | Stable compositions of high-concentration allotype-selected antibodies for small-volume administration | Li Zeng, Rohini Mitra, Hans J. Hansen, David M. Goldenberg | 2018-05-08 |
| 9963507 | Therapeutic use of anti-CD22 antibodies for inducing trogocytosis | Chien-Hsing Chang, David M. Goldenberg, Hans J. Hansen | 2018-05-08 |
| 9931413 | Tetrameric cytokines with improved biological activity | Chien-Hsing Chang, David M. Goldenberg | 2018-04-03 |
| 9879088 | Disease therapy by inducing immune response to Trop-2 expressing cells | Chien-Hsing Chang, David M. Goldenberg, Diane Rossi | 2018-01-30 |
| 9872920 | PEGylation by the dock and lock (DNL) technique | Chien-Hsing Chang, David M. Goldenberg, William J. McBride | 2018-01-23 |
| 9745374 | Fusion proteins containing recombinant cytotoxic RNAses | David M. Goldenberg, Hans J. Hansen, Chien-Hsing Chang, Sailaja S. Vanama | 2017-08-29 |
| 9737617 | Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases | Chien-Hsing Chang, David M. Goldenberg | 2017-08-22 |
| 9682143 | Combination therapy for inducing immune response to disease | Chien-Hsing Chang, David M. Goldenberg, Diane Rossi | 2017-06-20 |
| 9683050 | Stable compositions of high-concentration allotype-selected antibodies for small-volume administration | Li Zeng, Rohini Mitra, Hans J. Hansen, David M. Goldenberg | 2017-06-20 |
| 9670286 | Disease therapy by inducing immune response to Trop-2 expressing cells | Chien-Hsing Chang, David M. Goldenberg, Diane Rossi | 2017-06-06 |
| 9663576 | Therapeutic use of anti-CD22 antibodies for inducing trogocytosis | Chien-Hsing Chang, David M. Goldenberg, Hans J. Hansen | 2017-05-30 |
| 9617531 | Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock | Chien-Hsing Chang, David M. Goldenberg | 2017-04-11 |
| 9540618 | Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses | Chien-Hsing Chang, David M. Goldenberg, William J. McBride | 2017-01-10 |
| 9540435 | Stably tethered structures of defined compositions with multiple functions or binding specificities | Chien-Hsing Chang, David M. Goldenberg, William J. McBride | 2017-01-10 |
| 9498542 | Tetrameric cytokines with improved biological activity | Chien-Hsing Chang, David M. Goldenberg | 2016-11-22 |
| 9481878 | Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity | Chien-Hsing Chang, David M. Goldenberg | 2016-11-01 |
| 9475883 | Therapeutic use of anti-CD22 antibodies for inducing trogocytosis | Chien-Hsing Chang, David M. Goldenberg, Hans J. Hansen | 2016-10-25 |
| 9468689 | Ultrafiltration concentration of allotype selected antibodies for small-volume administration | Li Zeng, Rohini Mitra, Hans J. Hansen, David M. Goldenberg | 2016-10-18 |